Therapeutic Group: Cardiovascular Presentation Larcadip : Each film-coated tablet contains Lercanidipine Hydrochloride INN 10 mg. Description Larcadip is a selective calcium channel blocker of the dihydropyridine group and it inhibits the transmembrane influx of calcium into smooth muscle. The mechanism of its antihypertensive action is due to a direct relaxant effect on vascular smooth muscle, […]
Therapeutic Group: Oncology Presentation Lenvacent 4: Each capsule contains Lenvatinib mesylate INN equivalent to Lenvatinib 4 mg. Lenvacent 10: Each capsule contains Lenvatinib mesylate INN equivalent to Lenvatinib 10mg. Description Lenvatinib is a kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib […]
Therapeutic Group: Anti Rheumatic Drugs Presentation Nodia 10: Each film coated tablet contains Leflunomide INN 10 mg. Description Nodia is an isoxazole immunomodulatory agent which acts on the immune system, has been introduced recently as a disease-modifying antirheumatic drug. It inhibits dihydroorotate dehydrogenase (an enzyme involved in de novo pyrimidine synthesis) and has antiproliferative activity. […]
Therapeutic Group: Anti Bacterial Presentation TerabacTM Injection: Each vial contains Lefamulin acetate INN equivalent to Lefamulin 150 mg in 15 mL concentrate for solution for infusion. Description Lefamulin is a semi-synthetic pleuromutilin antibacterial agent for oral and intravenous administration. It inhibits bacterial protein synthesis by binding to the peptidyl transferase center of the 50S bacterial […]
Therapeutic Group: Anti Viral Presentation Twinvir: Each tablet contains Ledipasvir INN 90 mg and Sofosbuvir INN 400 mg Description It is a fixed-dose combination tablet containing Ledipasvir and Sofosbuvir for oral administration. Ledipasvir is an HCV NS5A inhibitor and Sofosbuvir is a nucleotide analog inhibitor of HCV NS5B polymerase. Indications Ledipasvir and Sofosbuvir combination is […]
Therapeutic Group: Drugs of Nervous System, Anti Migraine Lasgrain 50: Each tablet contains Lasmiditan Hemisuccinate INN equivalent to Lasmiditan 50 mg. Lasgrain 100: Each tablet contains Lasmiditan Hemisuccinate INN equivalent to Lasmiditan 100 mg. Description Lasmiditan is a serotonin (5-HT) 1F receptor agonist. It binds with high affinity to the 5-HT1F receptor. It presumably exerts […]
Therapeutic Group: Others Presentation Larocentâ„¢ 25: Each capsule contains Larotrectinib sulfate INN equivalent to Larotrectinib 25 mg Larocentâ„¢ 100: Each capsule contains Larotrectinib sulfate INN equivalent to Larotrectinib 100 mg Description Larotrectinib is an inhibitor of the tropomyosin receptor kinases (TRK), TRKA, TRKB, and TRKC. In a broad panel of purified enzyme assays, larotrectinib inhibited […]
Therapeutic Group: Oncology Presentation Lapacent 250: Each tablet contains Lapatinib ditosylate monohydrate INN equivalent to Lapatinib 250 mg Description Lapatinib is a 4-anilinoquinazoline kinase inhibitor of the intracellular tyrosine kinase domains of both Epidermal Growth Factor Receptor (EGFR [ErbB1]) and of Human Epidermal Receptor Type 2 (HER2 [ErbB2]) receptors (estimated Kiapp values of 3nM and […]
Therapeutic Group: Drugs of Nervous System Presentation Lamogin 2: Each chewable/dispersible tablet contains Lamotrigine BP 2 mg. Lamogin 5: Each chewable/dispersible tablet contains Lamotrigine BP 5 mg. Lamogin 25: Each tablet contains Lamotrigine BP 25 mg. Lamogin 50: Each tablet contains Lamotrigine BP 50 mg. Description The precise mechanism(s) by which lamotrigine exerts its anticonvulsant […]
Therapeutic Group: Anti Viral Presentation Lamivir: Each film coated tablet contains Lamivudine INN 100 mg. Description Lamivudine is a synthetic nucleoside analogue with activity against Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV). Indications Lamivir is indicated for the treatment of chronic hepatitis B associated with evidence of hepatitis B viral replication and active […]